Key Aim    

To evaluate two pain relief medications, oxycodone/naloxone prolonged-release (OXN PR) and oxycodone alone prolonged-release (Oxy PR) with respect to analgesic efficacy and constipation in patients with advanced cancer.
 

Principal Investigator

Dr Aaron Wong, Peter MacCallum Cancer Centre
 

Additional information

//www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377673&isReview=true
 

Funding    

Mundipharma

Enhance: A multi-centre, randomised, phase IV study to compare the efficacy of oxycodone/naloxone verses oxycodone prolonged release tablets in patients with advanced cancer